Neuromyelitis optica (NMO) is associated with antibodies to aquaporin 4 (AQP4). We hypothesized that antibodies to AQP4 can be triggered by exposure to environmental proteins. We compared human AQP4 to plant and bacterial proteins to investigate the occurrence of significantly similar structures and sequences. High similarity to a known epitope for NMO-IgG, AQP4(207-232), was observed for corn ZmTIP4-1. NMO and non-NMO sera were assessed for reactivity to AQP4(207-232) and the corn peptide. NMO patient serum showed reactivity to both peptides as well as to plant tissue. These findings warrant further investigation into the role of the environment in NMO etiology.
Introduction
Neuromyelitis optica (NMO, Devic's disease) is a severe relapsing disease that affects the gray and white matter in the brain and spinal cord causing inflammatory infiltrates, demyelination, axonal damage and necrosis resulting in sensory loss and paralysis (Jarius et al., 2008) . In three-quarters of cases, NMO is associated with the development of IgG1 antibodies that bind selectively to aquaporin 4 (AQP4) (Lennon et al., 2005; Jarius and Wildemann, 2010; Kim et al., 2010; Petzold et al., 2010; Dujmovic et al., 2011; Kim et al., 2012) , a water channel belonging to the aquaporin family. AQP4 is the predominant water channel in the CNS and is expressed in astrocytes, ependymocytes and endothelial cells, but not in neurons (Nagelhus et al., 2004; Nesic et al., 2006) . It is highly distributed in the astrocytic foot processes at the blood brain barrier in contact with brain microvessels or subarachnoid space (Nagelhus et al., 2004) . By contributing to regulation of activity-dependent extracellular volume changes that affect solute concentration and electrical activity, it helps to modulate normal neuronal transmission and excitability (Nagelhus et al., 2004) . NMO-IgG1 antibodies are damaging to astrocytes and presumably cause demyelination in the spinal cord and optic nerve (Kinoshita et al., 2009 (Kinoshita et al., , 2010 . The reason for the development of these autoantibodies and their precise role in the etiology of this disease is unclear (Roemer et al., 2007; Verkman et al., 2011) , although it has been recently shown that intracerebral injection of IgG from NMO patients and human complement into mice causes development of pathological features characteristic of NMO (Saadoun et al., 2010; Verkman et al., 2011) . The pathogenesis of NMO involves binding of IgG1 to AQP4 and complement activation, which leads to loss of AQP4 in lesions through tissue damage (Jarius et al., 2008; Phuan et al., 2012) . Deposition of immunoglobulins, complement and inflammatory infiltrates cause demyelination and tissue destruction that correlates with regions where AQP4 is expressed. Since IgG1 is produced in peripheral tissues, its access to the extracellular space of the CNS is greater in areas where blood brain barrier permeability is higher or compromised, allowing antibodies to reach their target antigens (Lennon et al., 2005; Bradl and Lassmann, 2008) . AQP4 has 6
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